| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.51e-33 | 46 | 53 | 17 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 4.13e-22 | 188 | 53 | 17 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 6.73e-11 | 891 | 53 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | heparin binding | 1.15e-05 | 192 | 53 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.48e-05 | 268 | 53 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.07e-04 | 323 | 53 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 4.49e-04 | 12 | 53 | 2 | GO:0048407 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 | 1.13e-14 | 377 | 51 | 15 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 | 1.17e-14 | 378 | 51 | 15 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 | 1.22e-14 | 379 | 51 | 15 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.23e-08 | 76 | 51 | 6 | GO:0030199 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL5A1 COL6A1 COL8A2 COL9A1 COL11A1 COL11A2 COL13A1 IRX5 ABR COL27A1 CNGA3 FOXG1 WNK4 | 9.00e-06 | 1269 | 51 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | connective tissue development | 2.04e-05 | 343 | 51 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.04e-05 | 343 | 51 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | cartilage development | 2.91e-05 | 243 | 51 | 6 | GO:0051216 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 6.03e-05 | 277 | 51 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.23e-04 | 615 | 51 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | tendon development | 1.25e-04 | 7 | 51 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 3.89e-04 | 12 | 51 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | sensory organ development | 3.92e-04 | 730 | 51 | 8 | GO:0007423 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 3.31e-28 | 88 | 54 | 17 | GO:0005581 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 ANO8 | 1.51e-19 | 332 | 54 | 18 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.29e-16 | 21 | 54 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.14e-14 | 530 | 54 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 3.62e-13 | 656 | 54 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 3.80e-13 | 658 | 54 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 7.43e-11 | 12 | 54 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 7.43e-11 | 12 | 54 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.62e-07 | 5 | 54 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | 7.17e-07 | 122 | 54 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 1.96e-05 | 3 | 54 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 1.96e-05 | 3 | 54 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 3.92e-05 | 4 | 54 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | collagen type V trimer | 3.92e-05 | 4 | 54 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 9.76e-05 | 6 | 54 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 9.76e-05 | 6 | 54 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.82e-04 | 8 | 54 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.82e-04 | 8 | 54 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL11A1 COL11A2 COL27A1 RP1L1 COL5A3 MTCL1 | 1.89e-04 | 1187 | 54 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 COL6A1 COL6A3 COL11A1 COL11A2 COL27A1 RP1L1 COL5A3 MTCL1 | 3.00e-03 | 1179 | 54 | 9 | GO:0099512 |
| GeneOntologyCellularComponent | chromatin | 4.18e-03 | 1480 | 54 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | fibrillar center | 7.66e-03 | 156 | 54 | 3 | GO:0001650 | |
| HumanPheno | Degenerative vitreoretinopathy | 6.96e-07 | 5 | 22 | 3 | HP:0007964 | |
| HumanPheno | Vitreoretinopathy | 1.81e-06 | 22 | 22 | 4 | HP:0007773 | |
| HumanPheno | Distal joint hypermobility | 5.78e-06 | 9 | 22 | 3 | HP:0020152 | |
| HumanPheno | Osteoarthritis | 6.45e-06 | 65 | 22 | 5 | HP:0002758 | |
| HumanPheno | Abnormality of upper limb joint | COL5A1 COL6A1 COL6A3 COL7A1 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL27A1 COL25A1 | 7.70e-06 | 705 | 22 | 12 | HP:0009810 |
| HumanPheno | Cigarette-paper scars | 8.23e-06 | 10 | 22 | 3 | HP:0001073 | |
| HumanPheno | Heterotropia | 1.26e-05 | 281 | 22 | 8 | HP:0032012 | |
| HumanPheno | Abnormality of the elbow | 1.29e-05 | 282 | 22 | 8 | HP:0009811 | |
| HumanPheno | Atrophic scars | 1.57e-05 | 37 | 22 | 4 | HP:0001075 | |
| HumanPheno | Esotropia | 1.73e-05 | 208 | 22 | 7 | HP:0000565 | |
| HumanPheno | Irregular distal femoral epiphysis | 1.78e-05 | 2 | 22 | 2 | HP:0006407 | |
| HumanPheno | Abnormal hip bone morphology | COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL27A1 COL25A1 | 2.61e-05 | 653 | 22 | 11 | HP:0003272 |
| HumanPheno | Esodeviation | 3.93e-05 | 236 | 22 | 7 | HP:0020045 | |
| HumanPheno | High myopia | 3.95e-05 | 94 | 22 | 5 | HP:0011003 | |
| HumanPheno | Knee pain | 4.57e-05 | 17 | 22 | 3 | HP:0030839 | |
| HumanPheno | Abnormal vitreous humor morphology | 4.87e-05 | 49 | 22 | 4 | HP:0004327 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 5.33e-05 | 3 | 22 | 2 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 5.33e-05 | 3 | 22 | 2 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 5.33e-05 | 3 | 22 | 2 | HP:0006190 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 5.33e-05 | 3 | 22 | 2 | HP:0003946 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL27A1 COL25A1 | 7.57e-05 | 730 | 22 | 11 | HP:0002644 |
| HumanPheno | Joint laxity | 7.70e-05 | 55 | 22 | 4 | HP:0001388 | |
| HumanPheno | Limb pain | 8.87e-05 | 57 | 22 | 4 | HP:0009763 | |
| HumanPheno | Amblyopia | 9.18e-05 | 112 | 22 | 5 | HP:0000646 | |
| HumanPheno | Reduced muscle collagen VI | 1.06e-04 | 4 | 22 | 2 | HP:0030095 | |
| HumanPheno | Ulnar deviated club hands | 1.06e-04 | 4 | 22 | 2 | HP:0006055 | |
| HumanPheno | Curved toe phalanx | 1.06e-04 | 4 | 22 | 2 | HP:0010176 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 1.06e-04 | 4 | 22 | 2 | HP:0010590 | |
| HumanPheno | Reduced arm span | 1.06e-04 | 4 | 22 | 2 | HP:0012770 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.06e-04 | 4 | 22 | 2 | HP:0012497 | |
| HumanPheno | Small epiphyses | 1.33e-04 | 24 | 22 | 3 | HP:0010585 | |
| HumanPheno | Irregular epiphyses | 1.51e-04 | 25 | 22 | 3 | HP:0010582 | |
| HumanPheno | Fragmented epiphyses | 1.77e-04 | 5 | 22 | 2 | HP:0100168 | |
| HumanPheno | Hyperplasia of midface | 1.77e-04 | 5 | 22 | 2 | HP:0012371 | |
| HumanPheno | Increased laxity of fingers | 1.77e-04 | 5 | 22 | 2 | HP:0006149 | |
| HumanPheno | Waddling gait | 1.86e-04 | 130 | 22 | 5 | HP:0002515 | |
| HumanPheno | Small joint hypermobilty | 1.88e-04 | 69 | 22 | 4 | HP:0430046 | |
| HumanPheno | Epiphyseal dysplasia | 2.38e-04 | 29 | 22 | 3 | HP:0002656 | |
| HumanPheno | Atypical scarring of skin | 2.46e-04 | 74 | 22 | 4 | HP:0000987 | |
| HumanPheno | Abnormality of radial epiphyses | 2.64e-04 | 6 | 22 | 2 | HP:0003999 | |
| HumanPheno | Abnormality of refraction | COL4A5 COL5A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 IRX5 COL25A1 CNGA3 | 3.40e-04 | 709 | 22 | 10 | HP:0000539 |
| HumanPheno | Myopia | 3.50e-04 | 447 | 22 | 8 | HP:0000545 | |
| HumanPheno | Abnormality of lower limb joint | COL5A1 COL6A1 COL6A3 COL7A1 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL27A1 COL25A1 | 3.66e-04 | 1027 | 22 | 12 | HP:0100491 |
| HumanPheno | Wrist hypermobility | 3.69e-04 | 7 | 22 | 2 | HP:0005072 | |
| HumanPheno | Abnormality of the epiphyses of the feet | 3.69e-04 | 7 | 22 | 2 | HP:0010631 | |
| HumanPheno | Dumbbell-shaped long bone | 3.69e-04 | 7 | 22 | 2 | HP:0000947 | |
| HumanPheno | Abnormal forearm morphology | 3.96e-04 | 239 | 22 | 6 | HP:0002973 | |
| HumanPheno | Abnormal cornea morphology | COL4A5 COL5A1 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 KIZ RP1L1 CNGA3 | 5.07e-04 | 744 | 22 | 10 | HP:0000481 |
| HumanPheno | Wrist flexion contracture | 5.35e-04 | 38 | 22 | 3 | HP:0001239 | |
| HumanPheno | Abnormal knee morphology | 5.98e-04 | 364 | 22 | 7 | HP:0034669 | |
| HumanPheno | Abnormality of the wrist | 6.14e-04 | 168 | 22 | 5 | HP:0003019 | |
| HumanPheno | Limited elbow movement | 6.14e-04 | 168 | 22 | 5 | HP:0002996 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 6.17e-04 | 94 | 22 | 4 | HP:0006500 | |
| HumanPheno | Arthralgia of the hip | 6.29e-04 | 9 | 22 | 2 | HP:0003365 | |
| HumanPheno | Abnormal hip joint morphology | 6.55e-04 | 490 | 22 | 8 | HP:0001384 | |
| HumanPheno | Hip dislocation | 6.62e-04 | 263 | 22 | 6 | HP:0002827 | |
| HumanPheno | Abnormality of the knee | 6.64e-04 | 491 | 22 | 8 | HP:0002815 | |
| HumanPheno | Lower limb pain | 6.70e-04 | 41 | 22 | 3 | HP:0012514 | |
| HumanPheno | Lumbar hyperlordosis | 7.50e-04 | 99 | 22 | 4 | HP:0002938 | |
| HumanPheno | Abnormal synovial membrane morphology | 7.81e-04 | 503 | 22 | 8 | HP:0005262 | |
| HumanPheno | Irregular femoral epiphysis | 7.85e-04 | 10 | 22 | 2 | HP:0006361 | |
| HumanPheno | Scarring | 8.40e-04 | 102 | 22 | 4 | HP:0100699 | |
| HumanPheno | Sensorineural hearing impairment | COL4A5 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 KIZ COL27A1 RP1L1 COL25A1 | 9.07e-04 | 958 | 22 | 11 | HP:0000407 |
| HumanPheno | Abnormal arm span | 9.57e-04 | 11 | 22 | 2 | HP:0012769 | |
| HumanPheno | Flat face | 9.71e-04 | 106 | 22 | 4 | HP:0012368 | |
| HumanPheno | Dermal atrophy | 1.01e-03 | 107 | 22 | 4 | HP:0004334 | |
| HumanPheno | Abnormality of the ankle | 1.13e-03 | 192 | 22 | 5 | HP:0003028 | |
| HumanPheno | Radial deviation of the hand | 1.14e-03 | 12 | 22 | 2 | HP:0009486 | |
| HumanPheno | Axial muscle weakness | 1.20e-03 | 50 | 22 | 3 | HP:0003327 | |
| HumanPheno | Abnormal posterior segment imaging | 1.20e-03 | 50 | 22 | 3 | HP:0030601 | |
| HumanPheno | Abnormal lens morphology | COL4A5 COL5A1 COL7A1 COL9A1 COL9A3 COL11A1 COL11A2 KIZ RP1L1 COL25A1 | 1.32e-03 | 837 | 22 | 10 | HP:0000517 |
| HumanPheno | Abnormal axial muscle morphology | 1.35e-03 | 52 | 22 | 3 | HP:0040286 | |
| HumanPheno | Finger joint hypermobility | 1.35e-03 | 52 | 22 | 3 | HP:0006094 | |
| HumanPheno | Bilateral coxa valga | 1.35e-03 | 13 | 22 | 2 | HP:0010665 | |
| HumanPheno | Weakness of muscles of respiration | 1.36e-03 | 116 | 22 | 4 | HP:0004347 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 1.37e-03 | 547 | 22 | 8 | HP:0100239 | |
| HumanPheno | Abnormal femoral neck/head morphology | 1.38e-03 | 201 | 22 | 5 | HP:0003366 | |
| HumanPheno | Micrognathia | COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL25A1 | 1.40e-03 | 843 | 22 | 10 | HP:0000347 |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 MNX1 COL25A1 | 1.41e-03 | 1008 | 22 | 11 | HP:0009122 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 IRX5 COL25A1 | 1.42e-03 | 845 | 22 | 10 | HP:0009118 |
| HumanPheno | Pain | COL4A5 COL5A1 COL6A1 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 MNX1 | 1.44e-03 | 846 | 22 | 10 | HP:0012531 |
| HumanPheno | Retinal detachment | 1.45e-03 | 118 | 22 | 4 | HP:0000541 | |
| HumanPheno | Postexertional symptom exacerbation | 1.57e-03 | 14 | 22 | 2 | HP:0030973 | |
| HumanPheno | Arthralgia | 1.58e-03 | 207 | 22 | 5 | HP:0002829 | |
| HumanPheno | Ankle flexion contracture | 1.67e-03 | 56 | 22 | 3 | HP:0006466 | |
| HumanPheno | Pes valgus | 1.67e-03 | 56 | 22 | 3 | HP:0008081 | |
| HumanPheno | Bowing of the long bones | 1.74e-03 | 316 | 22 | 6 | HP:0006487 | |
| HumanPheno | Platyspondyly | 1.74e-03 | 124 | 22 | 4 | HP:0000926 | |
| HumanPheno | Abnormality of hand joint mobility | 1.76e-03 | 57 | 22 | 3 | HP:0006256 | |
| HumanPheno | Lower extremity joint dislocation | 1.79e-03 | 318 | 22 | 6 | HP:0030311 | |
| HumanPheno | Visual loss | 1.86e-03 | 718 | 22 | 9 | HP:0000572 | |
| HumanPheno | Anomaly of the limb diaphyses | 1.91e-03 | 322 | 22 | 6 | HP:0006504 | |
| HumanPheno | Spinal rigidity | 1.94e-03 | 59 | 22 | 3 | HP:0003306 | |
| HumanPheno | Abnormal morphology of the radius | 1.95e-03 | 217 | 22 | 5 | HP:0002818 | |
| HumanPheno | Ankle contracture | 2.04e-03 | 60 | 22 | 3 | HP:0034677 | |
| HumanPheno | Hypoplastic ischia | 2.06e-03 | 16 | 22 | 2 | HP:0003175 | |
| HumanPheno | Reduced visual acuity | 2.22e-03 | 589 | 22 | 8 | HP:0007663 | |
| HumanPheno | Foot joint contracture | 2.31e-03 | 334 | 22 | 6 | HP:0008366 | |
| HumanPheno | Diaphragmatic weakness | 2.33e-03 | 17 | 22 | 2 | HP:0009113 | |
| HumanPheno | Hypoplastic ilia | 2.35e-03 | 63 | 22 | 3 | HP:0000946 | |
| Domain | Collagen | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 7.97e-28 | 85 | 53 | 17 | PF01391 |
| Domain | Collagen | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 7.97e-28 | 85 | 53 | 17 | IPR008160 |
| Domain | TSPN | COL5A1 COL24A1 COL9A1 COL11A1 COL11A2 COL27A1 COL5A3 COL22A1 | 1.15e-15 | 23 | 53 | 8 | SM00210 |
| Domain | NC1_FIB | 1.78e-13 | 11 | 53 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 1.78e-13 | 11 | 53 | 6 | IPR000885 | |
| Domain | Fib_collagen_C | 1.78e-13 | 11 | 53 | 6 | PD002078 | |
| Domain | COLFI | 1.78e-13 | 11 | 53 | 6 | SM00038 | |
| Domain | COLFI | 1.78e-13 | 11 | 53 | 6 | PF01410 | |
| Domain | Laminin_G | COL5A1 COL24A1 COL9A1 COL11A1 COL11A2 COL27A1 COL5A3 COL22A1 | 4.16e-12 | 58 | 53 | 8 | IPR001791 |
| Domain | ConA-like_dom | COL5A1 COL24A1 COL9A1 COL11A1 COL11A2 COL27A1 COL5A3 COL22A1 TRIM47 | 1.01e-08 | 219 | 53 | 9 | IPR013320 |
| Domain | Laminin_G_2 | 9.25e-08 | 40 | 53 | 5 | PF02210 | |
| Domain | - | 2.79e-07 | 95 | 53 | 6 | 2.60.120.200 | |
| Domain | LamG | 7.21e-06 | 44 | 53 | 4 | SM00282 | |
| Domain | VWA | 1.90e-05 | 56 | 53 | 4 | PF00092 | |
| Domain | - | 5.74e-05 | 74 | 53 | 4 | 3.40.50.410 | |
| Domain | VWFA | 8.58e-05 | 82 | 53 | 4 | PS50234 | |
| Domain | VWA | 9.43e-05 | 84 | 53 | 4 | SM00327 | |
| Domain | C4 | 1.18e-04 | 6 | 53 | 2 | SM00111 | |
| Domain | - | 1.18e-04 | 6 | 53 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.18e-04 | 6 | 53 | 2 | IPR001442 | |
| Domain | NC1_IV | 1.18e-04 | 6 | 53 | 2 | PS51403 | |
| Domain | C4 | 1.18e-04 | 6 | 53 | 2 | PF01413 | |
| Domain | LAM_G_DOMAIN | 1.70e-04 | 38 | 53 | 3 | PS50025 | |
| Domain | VWF_A | 1.78e-04 | 99 | 53 | 4 | IPR002035 | |
| Domain | - | 1.17e-03 | 18 | 53 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.17e-03 | 18 | 53 | 2 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 1.31e-03 | 19 | 53 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.31e-03 | 19 | 53 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.31e-03 | 19 | 53 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 1.92e-03 | 23 | 53 | 2 | IPR002223 | |
| Domain | PX | 6.93e-03 | 44 | 53 | 2 | SM00312 | |
| Domain | - | 8.44e-03 | 283 | 53 | 4 | 1.10.10.60 | |
| Domain | PX | 8.53e-03 | 49 | 53 | 2 | PF00787 | |
| Domain | PX | 8.87e-03 | 50 | 53 | 2 | PS50195 | |
| Domain | - | 9.22e-03 | 51 | 53 | 2 | 3.30.1520.10 | |
| Domain | Phox | 9.57e-03 | 52 | 53 | 2 | IPR001683 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.04e-33 | 44 | 41 | 17 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 4.94e-30 | 67 | 41 | 17 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL22A1 COL25A1 | 2.94e-29 | 41 | 41 | 15 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.32e-27 | 90 | 41 | 17 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL22A1 COL25A1 | 3.15e-26 | 61 | 41 | 15 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL22A1 COL25A1 | 1.24e-24 | 76 | 41 | 15 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 COL5A3 | 5.23e-24 | 61 | 41 | 14 | M27103 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL25A1 | 1.11e-23 | 64 | 41 | 14 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL5A3 | 6.97e-21 | 50 | 41 | 12 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL11A1 COL11A2 COL13A1 COL5A3 COL25A1 | 1.52e-20 | 53 | 41 | 12 | MM14566 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 | 3.61e-19 | 46 | 41 | 11 | M198 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL25A1 | 1.31e-18 | 140 | 41 | 14 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 2.29e-18 | 300 | 41 | 17 | M610 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 | 1.07e-16 | 74 | 41 | 11 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL13A1 COL5A3 | 1.46e-16 | 76 | 41 | 11 | MM14867 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL5A3 COL22A1 COL25A1 | 2.39e-16 | 258 | 41 | 15 | MM14572 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL11A1 COL11A2 COL13A1 COL5A3 COL25A1 | 2.81e-16 | 114 | 41 | 12 | MM14571 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.04e-16 | 20 | 41 | 8 | MM15061 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL13A1 COL5A3 | 5.35e-16 | 85 | 41 | 11 | M16441 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.14e-13 | 38 | 41 | 8 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.72e-13 | 42 | 41 | 8 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.69e-12 | 57 | 41 | 8 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.27e-12 | 58 | 41 | 8 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.55e-12 | 63 | 41 | 8 | M11187 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.05e-11 | 76 | 41 | 8 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.33e-10 | 30 | 41 | 6 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.54e-10 | 32 | 41 | 6 | MM14924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.05e-10 | 66 | 41 | 7 | M18 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.72e-09 | 41 | 41 | 6 | M27778 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.95e-09 | 84 | 41 | 7 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.06e-09 | 47 | 41 | 6 | MM14925 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.66e-08 | 59 | 41 | 6 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 COL5A3 | 2.14e-08 | 532 | 41 | 12 | M27870 |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.82e-08 | 79 | 41 | 6 | M27643 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.43e-07 | 43 | 41 | 5 | M39565 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.31e-07 | 19 | 41 | 4 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL5A3 | 2.32e-07 | 418 | 41 | 10 | MM15587 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.98e-07 | 261 | 41 | 8 | MM15676 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.50e-06 | 199 | 41 | 7 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.60e-06 | 30 | 41 | 4 | MM15517 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.01e-05 | 15 | 41 | 3 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.13e-05 | 67 | 41 | 4 | MM15345 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 8.28e-05 | 502 | 41 | 8 | MM14537 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.78e-05 | 30 | 41 | 3 | M27216 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 1.23e-04 | 6 | 41 | 2 | M39872 | |
| Pathway | WP_FOCAL_ADHESION | 1.98e-04 | 187 | 41 | 5 | MM15913 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.12e-04 | 575 | 41 | 8 | M29853 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.66e-04 | 10 | 41 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.66e-04 | 10 | 41 | 2 | MM1560 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.09e-04 | 339 | 41 | 6 | M39736 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.35e-04 | 12 | 41 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.31e-04 | 13 | 41 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.35e-04 | 14 | 41 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.35e-04 | 14 | 41 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.46e-04 | 15 | 41 | 2 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-03 | 18 | 41 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-03 | 18 | 41 | 2 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.52e-03 | 20 | 41 | 2 | M15394 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.74e-03 | 302 | 41 | 5 | M39719 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.01e-03 | 23 | 41 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.01e-03 | 23 | 41 | 2 | MM1427 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.43e-03 | 326 | 41 | 5 | MM15917 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.77e-03 | 27 | 41 | 2 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.97e-03 | 28 | 41 | 2 | MM15957 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_2 | 3.87e-03 | 32 | 41 | 2 | M39497 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL11A1 COL11A2 COL13A1 COL5A3 | 2.12e-18 | 135 | 54 | 12 | 28675934 |
| Pubmed | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL9A3 COL13A1 COL27A1 COL5A3 COL25A1 | 2.90e-17 | 167 | 54 | 12 | 22159717 | |
| Pubmed | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL11A1 COL11A2 COL27A1 COL5A3 COL22A1 | 5.13e-17 | 175 | 54 | 12 | 28071719 | |
| Pubmed | COL4A2 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL13A1 COL25A1 | 6.74e-16 | 153 | 54 | 11 | 25037231 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 6.69e-12 | 62 | 54 | 7 | 28344315 | |
| Pubmed | 3.30e-11 | 39 | 54 | 6 | 33580754 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 10722718 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 15922184 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 20301479 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.62e-10 | 8 | 54 | 4 | 20059976 | |
| Pubmed | 3.87e-10 | 25 | 54 | 5 | 19180518 | ||
| Pubmed | 1.08e-09 | 10 | 54 | 4 | 2446864 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.08e-09 | 10 | 54 | 4 | 15345741 | |
| Pubmed | 1.27e-09 | 210 | 54 | 8 | 16537572 | ||
| Pubmed | 1.46e-09 | 32 | 54 | 5 | 23154389 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 34009784 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 36553626 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 6.99e-09 | 15 | 54 | 4 | 9832566 | |
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 6.99e-09 | 15 | 54 | 4 | 10579729 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 1.41e-08 | 4 | 54 | 3 | 17683922 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 21467034 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 7.05e-08 | 6 | 54 | 3 | 17029294 | |
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 7.05e-08 | 6 | 54 | 3 | 12883905 | |
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 7.05e-08 | 6 | 54 | 3 | 8563024 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 17876790 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 8.87e-08 | 27 | 54 | 4 | 12192060 | |
| Pubmed | 1.20e-07 | 29 | 54 | 4 | 22613833 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 9164858 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 1.97e-07 | 8 | 54 | 3 | 12766770 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.36e-07 | 86 | 54 | 5 | 28327460 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.32e-07 | 97 | 54 | 5 | 27559042 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 5.28e-07 | 101 | 54 | 5 | 20551380 | |
| Pubmed | 1.13e-06 | 50 | 54 | 4 | 23658023 | ||
| Pubmed | Subtypes of medulloblastoma have distinct developmental origins. | 1.93e-06 | 57 | 54 | 4 | 21150899 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 7560887 | ||
| Pubmed | Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. | 2.37e-06 | 2 | 54 | 2 | 12673280 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 32389683 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 33348901 | ||
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 2.37e-06 | 2 | 54 | 2 | 11342118 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11780999 | ||
| Pubmed | Polypeptide composition of the mammalian tectorial membrane. | 2.37e-06 | 2 | 54 | 2 | 3542919 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18706356 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 7721876 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 26910848 | ||
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 2.37e-06 | 2 | 54 | 2 | 9560475 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12021518 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 2591970 | ||
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 2.37e-06 | 2 | 54 | 2 | 18040076 | |
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 2.37e-06 | 2 | 54 | 2 | 30706156 | |
| Pubmed | Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients. | 2.37e-06 | 2 | 54 | 2 | 17554254 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25240749 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 33188786 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 2.37e-06 | 17 | 54 | 3 | 10213384 | |
| Pubmed | 2.54e-06 | 61 | 54 | 4 | 11180952 | ||
| Pubmed | 3.08e-06 | 64 | 54 | 4 | 22261194 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 7.09e-06 | 3 | 54 | 2 | 25204870 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27628582 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 26429145 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 6501291 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15908193 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 7780011 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 20358595 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 20301676 | ||
| Pubmed | The role of polymorphisms of genes encoding collagen IX and XI in lumbar disc disease. | 7.09e-06 | 3 | 54 | 2 | 24636772 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 37158802 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 7.09e-06 | 3 | 54 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 7.09e-06 | 3 | 54 | 2 | 12011280 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 21459131 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 36982625 | ||
| Pubmed | Identification of a novel common genetic risk factor for lumbar disk disease. | 7.09e-06 | 3 | 54 | 2 | 11308397 | |
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 7.09e-06 | 3 | 54 | 2 | 3198591 | |
| Pubmed | The NC2 domain of type IX collagen determines the chain register of the triple helix. | 7.09e-06 | 3 | 54 | 2 | 23132862 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 7346227 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 3665927 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 7.09e-06 | 3 | 54 | 2 | 18366090 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15141750 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 7.09e-06 | 3 | 54 | 2 | 1571108 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 7750564 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 24443028 | ||
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 7.09e-06 | 3 | 54 | 2 | 15136578 | |
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 7.09e-06 | 3 | 54 | 2 | 15563506 | |
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 7.09e-06 | 3 | 54 | 2 | 9582436 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 24801232 | ||
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 7.09e-06 | 3 | 54 | 2 | 9520112 | |
| Pubmed | Structural insight for chain selection and stagger control in collagen. | 7.09e-06 | 3 | 54 | 2 | 27897211 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 1429648 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 16141002 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 31090205 | ||
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 7.09e-06 | 3 | 54 | 2 | 3348212 | |
| Pubmed | Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. | 7.09e-06 | 3 | 54 | 2 | 3473493 | |
| Pubmed | 1.06e-05 | 689 | 54 | 8 | 36543142 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 18761340 | ||
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 1.42e-05 | 4 | 54 | 2 | 25073002 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 12874293 | ||
| Pubmed | Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. | 1.42e-05 | 4 | 54 | 2 | 8660302 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 11724554 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 8806434 | ||
| Pubmed | Targeted next-generation sequencing reveals multiple deleterious variants in OPLL-associated genes. | 1.42e-05 | 4 | 54 | 2 | 27246988 | |
| Pubmed | Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1. | 1.42e-05 | 4 | 54 | 2 | 9840442 | |
| Interaction | COLGALT2 interactions | 2.45e-08 | 67 | 54 | 6 | int:COLGALT2 | |
| Interaction | COL9A1 interactions | 3.23e-08 | 13 | 54 | 4 | int:COL9A1 | |
| Interaction | COL8A2 interactions | 9.01e-08 | 42 | 54 | 5 | int:COL8A2 | |
| Interaction | LAIR2 interactions | 1.99e-07 | 49 | 54 | 5 | int:LAIR2 | |
| Interaction | COL2A1 interactions | 7.73e-07 | 64 | 54 | 5 | int:COL2A1 | |
| Interaction | MAG interactions | 1.04e-06 | 29 | 54 | 4 | int:MAG | |
| Interaction | MMP2 interactions | 3.57e-06 | 87 | 54 | 5 | int:MMP2 | |
| Interaction | PLOD1 interactions | 1.23e-05 | 292 | 54 | 7 | int:PLOD1 | |
| Interaction | COL5A1 interactions | 2.76e-05 | 65 | 54 | 4 | int:COL5A1 | |
| Interaction | MMP9 interactions | 3.11e-05 | 67 | 54 | 4 | int:MMP9 | |
| Interaction | COL4A2 interactions | 4.86e-05 | 75 | 54 | 4 | int:COL4A2 | |
| Interaction | C1QC interactions | 1.94e-04 | 42 | 54 | 3 | int:C1QC | |
| Interaction | DCN interactions | 2.08e-04 | 43 | 54 | 3 | int:DCN | |
| Interaction | ADAMTS5 interactions | 2.51e-04 | 9 | 54 | 2 | int:ADAMTS5 | |
| Interaction | C1QTNF1 interactions | 2.71e-04 | 47 | 54 | 3 | int:C1QTNF1 | |
| Interaction | COL5A3 interactions | 3.13e-04 | 10 | 54 | 2 | int:COL5A3 | |
| Cytoband | 16q12.2 | 4.33e-04 | 26 | 54 | 2 | 16q12.2 | |
| Cytoband | 3p21.1 | 1.13e-03 | 42 | 54 | 2 | 3p21.1 | |
| GeneFamily | Collagens | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 6.52e-35 | 46 | 42 | 17 | 490 |
| GeneFamily | Collagens|Collagen proteoglycans | 5.24e-05 | 5 | 42 | 2 | 575 | |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 5.27e-36 | 43 | 54 | 17 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 8.58e-36 | 44 | 54 | 17 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 3.34e-21 | 270 | 54 | 17 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 4.58e-21 | 275 | 54 | 17 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 9.50e-12 | 1008 | 54 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.25e-11 | 1026 | 54 | 17 | M5889 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 3.03e-09 | 111 | 54 | 7 | M45685 | |
| Coexpression | GU_PDEF_TARGETS_UP | 7.42e-09 | 71 | 54 | 6 | M3955 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.77e-07 | 200 | 54 | 7 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.35e-06 | 11 | 54 | 3 | M47997 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.39e-06 | 40 | 54 | 4 | M5887 | |
| Coexpression | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN | 1.70e-06 | 42 | 54 | 4 | M1552 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 3.45e-06 | 50 | 54 | 4 | MM403 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 4.32e-06 | 117 | 54 | 5 | M45663 | |
| Coexpression | KANG_AR_TARGETS_UP | 5.51e-06 | 17 | 54 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 5.51e-06 | 17 | 54 | 3 | M2223 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 6.60e-06 | 18 | 54 | 3 | M47984 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 7.21e-06 | 493 | 54 | 8 | M19391 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 8.58e-06 | 505 | 54 | 8 | M39167 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 1.07e-05 | 21 | 54 | 3 | MM1196 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 1.19e-05 | 68 | 54 | 4 | M45669 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 1.24e-05 | 22 | 54 | 3 | M1627 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.42e-05 | 23 | 54 | 3 | M48001 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.66e-05 | 74 | 54 | 4 | M13547 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A2 COL5A1 COL6A1 COL6A3 COL7A1 COL11A1 IRX5 COL5A3 TRIM47 | 2.45e-05 | 767 | 54 | 9 | M39209 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.91e-05 | 29 | 54 | 3 | MM17055 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 3.57e-05 | 31 | 54 | 3 | M18395 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 4.32e-05 | 33 | 54 | 3 | M9167 | |
| Coexpression | GSE22045_TREG_VS_TCONV_UP | 4.39e-05 | 189 | 54 | 5 | M4400 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.16e-05 | 35 | 54 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.62e-05 | 36 | 54 | 3 | MM1212 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 8.43e-05 | 352 | 54 | 6 | M17471 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.11e-04 | 120 | 54 | 4 | M42505 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 1.26e-04 | 47 | 54 | 3 | M8364 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.38e-04 | 385 | 54 | 6 | M39264 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 1.60e-04 | 51 | 54 | 3 | MM689 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.06e-04 | 141 | 54 | 4 | M10381 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.35e-04 | 146 | 54 | 4 | MM973 | |
| Coexpression | DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS | 2.61e-04 | 150 | 54 | 4 | M40107 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.61e-04 | 150 | 54 | 4 | M9146 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 2.71e-04 | 12 | 54 | 2 | MM3646 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 2.71e-04 | 12 | 54 | 2 | M47983 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A5 COL5A1 COL9A1 COL11A2 BRME1 COL5A3 COL22A1 SERINC5 TRIM47 | 2.77e-04 | 1054 | 54 | 9 | M45798 |
| Coexpression | BENPORATH_EED_TARGETS | 2.87e-04 | 1059 | 54 | 9 | M7617 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.87e-04 | 62 | 54 | 3 | M16774 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 3.05e-04 | 286 | 54 | 5 | M45746 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN | 3.10e-04 | 287 | 54 | 5 | M40958 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 3.15e-04 | 64 | 54 | 3 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 3.30e-04 | 65 | 54 | 3 | M39309 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 3.60e-04 | 650 | 54 | 7 | M8448 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 3.79e-04 | 465 | 54 | 6 | M9192 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL6A1 COL6A3 COL9A1 COL11A1 COL11A2 NISCH COL27A1 SERINC5 | 3.84e-04 | 1102 | 54 | 9 | M2369 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 3.93e-04 | 69 | 54 | 3 | M10165 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 4.18e-04 | 1115 | 54 | 9 | M10371 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL6A1 COL6A3 COL9A1 COL11A1 COL11A2 NISCH COL27A1 SERINC5 | 4.43e-04 | 1124 | 54 | 9 | MM1070 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 4.61e-04 | 313 | 54 | 5 | M40228 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | NELFE COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL11A1 COL11A2 NUDT21 | 4.79e-04 | 1136 | 54 | 9 | M2247 |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 4.95e-04 | 318 | 54 | 5 | M41707 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 5.22e-04 | 76 | 54 | 3 | M11825 | |
| Coexpression | PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP | 5.43e-04 | 77 | 54 | 3 | M2364 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 5.55e-04 | 17 | 54 | 2 | M47995 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 6.01e-04 | 187 | 54 | 4 | M2654 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 6.50e-04 | 191 | 54 | 4 | M40019 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 6.63e-04 | 192 | 54 | 4 | M42501 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN | 6.63e-04 | 192 | 54 | 4 | M6064 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP | 6.76e-04 | 83 | 54 | 3 | M15975 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 6.76e-04 | 83 | 54 | 3 | M2448 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 6.89e-04 | 194 | 54 | 4 | M39122 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | NELFE COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL11A1 COL11A2 NUDT21 | 7.02e-04 | 1198 | 54 | 9 | MM1062 |
| Coexpression | PEREZ_TP53_TARGETS | 7.14e-04 | 1201 | 54 | 9 | M4391 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_DN | 7.44e-04 | 198 | 54 | 4 | M5208 | |
| Coexpression | GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS | 7.58e-04 | 199 | 54 | 4 | M43608 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 7.72e-04 | 200 | 54 | 4 | M3575 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP | 7.72e-04 | 200 | 54 | 4 | M5241 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN | 7.72e-04 | 200 | 54 | 4 | M8496 | |
| Coexpression | PEREZ_TP63_TARGETS | 8.23e-04 | 356 | 54 | 5 | M10761 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 8.53e-04 | 21 | 54 | 2 | M4767 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 8.77e-04 | 207 | 54 | 4 | M14566 | |
| Coexpression | DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS | 8.83e-04 | 91 | 54 | 3 | M40240 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 8.83e-04 | 91 | 54 | 3 | M40180 | |
| Coexpression | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC | 9.37e-04 | 22 | 54 | 2 | MM779 | |
| Coexpression | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC | 9.37e-04 | 22 | 54 | 2 | M1867 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 9.42e-04 | 211 | 54 | 4 | M12225 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 1.18e-03 | 224 | 54 | 4 | M9893 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 1.18e-03 | 795 | 54 | 7 | M39050 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.55e-07 | 307 | 52 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | COL24A1 COL8A2 COL9A1 TMEM169 B4GALNT4 COL13A1 IRX5 GON4L COL25A1 WNK4 PPP1R12C | 5.63e-06 | 855 | 52 | 11 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.43e-06 | 197 | 52 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | COL6A1 COL24A1 COL6A3 COL8A2 COL9A3 IRX5 ZBTB47 SNX15 COL25A1 USF2 FOXG1 | 1.90e-05 | 973 | 52 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.06e-05 | 66 | 52 | 4 | BM Top 100 - endometrium | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.64e-05 | 241 | 52 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 8.92e-05 | 300 | 52 | 6 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL5A1 COL24A1 COL6A3 COL8A2 COL9A1 COL11A1 COL5A3 COL25A1 WNK4 PDZD4 | 1.14e-04 | 981 | 52 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.23e-04 | 104 | 52 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.55e-04 | 642 | 52 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | COL24A1 COL9A1 TMEM169 COL9A3 COL11A1 B4GALNT4 EVX1 MTCL1 COL25A1 | 1.61e-04 | 827 | 52 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | 1.76e-04 | 837 | 52 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.78e-04 | 655 | 52 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | COL6A1 COL24A1 COL6A3 COL8A2 COL9A3 CYTH3 ZBTB47 C1orf216 COL25A1 | 2.52e-04 | 878 | 52 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.65e-04 | 234 | 52 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 2.81e-04 | 129 | 52 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.82e-04 | 371 | 52 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.22e-04 | 244 | 52 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.53e-04 | 137 | 52 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 3.53e-04 | 249 | 52 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.57e-04 | 726 | 52 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.01e-04 | 256 | 52 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.21e-04 | 744 | 52 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.10e-04 | 151 | 52 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#4_top-relative-expression-ranked_200 | 5.25e-04 | 14 | 52 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.52e-04 | 589 | 52 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.65e-04 | 276 | 52 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - cervix | 5.68e-04 | 66 | 52 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | 5.73e-04 | 424 | 52 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 5.80e-04 | 984 | 52 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | COL5A1 COL6A3 COL7A1 COL8A2 COL11A1 CYTH3 ZBTB47 COL5A3 WNK4 | 6.05e-04 | 990 | 52 | 9 | JC_fibro_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A1 TMEM169 COL11A1 COL11A2 CHGA PDZD4 | 6.14e-04 | 992 | 52 | 9 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL6A3 COL8A2 COL9A1 TMEM169 COL11A1 EVX1 CHGA COL25A1 PDZD4 | 6.23e-04 | 994 | 52 | 9 | PCBC_EB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3 | 6.34e-04 | 160 | 52 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 6.75e-04 | 70 | 52 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | COL5A1 COL9A3 COL11A1 B4GALNT4 IRX5 COL27A1 ZBTB47 C1orf216 WNK4 PDZD4 | 6.89e-04 | 1228 | 52 | 10 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL7A1 COL9A1 TMEM169 COL9A3 B4GALNT4 COL13A1 EFHD2 COL22A1 COL25A1 ANO8 | 7.66e-04 | 1245 | 52 | 10 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.98e-04 | 298 | 52 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 8.31e-04 | 172 | 52 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.47e-04 | 457 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 8.87e-04 | 175 | 52 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.90e-04 | 834 | 52 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.16e-04 | 464 | 52 | 6 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.66e-04 | 311 | 52 | 5 | gudmap_developingKidney_e13.5_podocyte cells_1000_k4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A5 COL7A1 COL9A1 TMEM169 COL11A1 ABR COL22A1 SERINC5 ANO8 | 1.09e-03 | 1075 | 52 | 9 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.14e-03 | 323 | 52 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 1.16e-03 | 486 | 52 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.18e-03 | 487 | 52 | 6 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 1.20e-03 | 489 | 52 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.26e-03 | 330 | 52 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.36e-03 | 89 | 52 | 3 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.36e-03 | 89 | 52 | 3 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 1.49e-03 | 92 | 52 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.64e-03 | 95 | 52 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.65e-03 | 207 | 52 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 COL4A5 COL5A1 COL6A1 COL9A3 COL11A1 COL13A1 COL27A1 EFHD2 | 1.77e-03 | 1153 | 52 | 9 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.79e-03 | 529 | 52 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.89e-03 | 100 | 52 | 3 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.89e-03 | 100 | 52 | 3 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.94e-03 | 731 | 52 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.98e-03 | 734 | 52 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.05e-03 | 951 | 52 | 8 | Arv_EB-LF_2500_K2 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL5A1 COL6A1 COL24A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 WNK4 | 2.60e-14 | 188 | 54 | 10 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 SERINC5 COL25A1 TRIM47 | 2.21e-12 | 197 | 54 | 9 | 6e111ba16fc8adde782b3f7da250248cddf11228 |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 SERINC5 COL25A1 TRIM47 | 2.31e-12 | 198 | 54 | 9 | 71e847e8c24744d6df4a960348ad2ecf310373b4 |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-11 | 166 | 54 | 8 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-11 | 166 | 54 | 8 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.56e-11 | 178 | 54 | 8 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.45e-11 | 182 | 54 | 8 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-11 | 183 | 54 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-11 | 183 | 54 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-11 | 183 | 54 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.21e-11 | 185 | 54 | 8 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.21e-11 | 185 | 54 | 8 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-11 | 188 | 54 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.46e-11 | 195 | 54 | 8 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-10 | 197 | 54 | 8 | 8786125b669d5d0b15e12df0ade6b319f09f7333 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-10 | 197 | 54 | 8 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-10 | 197 | 54 | 8 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-10 | 198 | 54 | 8 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-10 | 198 | 54 | 8 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-10 | 198 | 54 | 8 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-10 | 198 | 54 | 8 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-10 | 198 | 54 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-10 | 198 | 54 | 8 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-10 | 199 | 54 | 8 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.11e-10 | 199 | 54 | 8 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-10 | 199 | 54 | 8 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.50e-10 | 157 | 54 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-09 | 167 | 54 | 7 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-09 | 176 | 54 | 7 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.89e-09 | 176 | 54 | 7 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.96e-09 | 177 | 54 | 7 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-09 | 180 | 54 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-09 | 180 | 54 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.57e-09 | 184 | 54 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.09e-09 | 189 | 54 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.33e-09 | 191 | 54 | 7 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.45e-09 | 192 | 54 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.45e-09 | 192 | 54 | 7 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 3.58e-09 | 193 | 54 | 7 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-09 | 193 | 54 | 7 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 3.58e-09 | 193 | 54 | 7 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-09 | 193 | 54 | 7 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.71e-09 | 194 | 54 | 7 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-09 | 194 | 54 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 3.84e-09 | 195 | 54 | 7 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-09 | 195 | 54 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 3.98e-09 | 196 | 54 | 7 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-09 | 197 | 54 | 7 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.27e-09 | 198 | 54 | 7 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.27e-09 | 198 | 54 | 7 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-09 | 198 | 54 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-09 | 198 | 54 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-09 | 198 | 54 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-09 | 199 | 54 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-09 | 199 | 54 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-09 | 200 | 54 | 7 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-09 | 200 | 54 | 7 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-09 | 200 | 54 | 7 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-09 | 200 | 54 | 7 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-09 | 200 | 54 | 7 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-09 | 200 | 54 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-09 | 200 | 54 | 7 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-08 | 153 | 54 | 6 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-08 | 153 | 54 | 6 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-08 | 153 | 54 | 6 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.98e-08 | 159 | 54 | 6 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-08 | 167 | 54 | 6 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-08 | 167 | 54 | 6 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-08 | 167 | 54 | 6 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-08 | 167 | 54 | 6 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.13e-08 | 171 | 54 | 6 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.34e-08 | 172 | 54 | 6 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-08 | 173 | 54 | 6 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.03e-08 | 175 | 54 | 6 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.03e-08 | 175 | 54 | 6 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.03e-08 | 175 | 54 | 6 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.52e-08 | 177 | 54 | 6 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.77e-08 | 178 | 54 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-08 | 180 | 54 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.58e-08 | 181 | 54 | 6 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.87e-08 | 182 | 54 | 6 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.87e-08 | 182 | 54 | 6 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.87e-08 | 182 | 54 | 6 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.87e-08 | 182 | 54 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.87e-08 | 182 | 54 | 6 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.87e-08 | 182 | 54 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 9.46e-08 | 184 | 54 | 6 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.46e-08 | 184 | 54 | 6 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.77e-08 | 185 | 54 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.77e-08 | 185 | 54 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-08 | 185 | 54 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-08 | 185 | 54 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-07 | 186 | 54 | 6 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 186 | 54 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-07 | 187 | 54 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-07 | 188 | 54 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-07 | 188 | 54 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-07 | 188 | 54 | 6 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.07e-07 | 188 | 54 | 6 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| Computational | Adhesion molecules. | 9.78e-09 | 141 | 34 | 8 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.12e-04 | 50 | 34 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Drug | GK-101 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.67e-31 | 36 | 54 | 15 | CID000161853 |
| Drug | Madecassol | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.42e-29 | 46 | 54 | 15 | CID000108062 |
| Drug | d-indobufen | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.06e-28 | 50 | 54 | 15 | CID000044562 |
| Drug | ridogrel | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.10e-28 | 52 | 54 | 15 | CID005362391 |
| Drug | NSC49633 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.92e-28 | 53 | 54 | 15 | CID000023340 |
| Drug | AC1LAKND | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.28e-27 | 62 | 54 | 15 | CID000470146 |
| Drug | BAPN | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.15e-26 | 71 | 54 | 15 | CID000001647 |
| Drug | malotilate | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.15e-26 | 71 | 54 | 15 | CID000004006 |
| Drug | AC1NMZ1B | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.03e-25 | 75 | 54 | 15 | CID005034185 |
| Drug | strontium ranelate | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.59e-25 | 77 | 54 | 15 | CID006918182 |
| Drug | halofuginone lactate | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 7.98e-25 | 85 | 54 | 15 | CID000062891 |
| Drug | 4-hydroxyproline | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.41e-24 | 91 | 54 | 15 | CID000000825 |
| Drug | Selara | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 FOXG1 | 4.47e-24 | 125 | 54 | 16 | CID000150310 |
| Drug | DMSe | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL5A3 COL22A1 COL25A1 | 1.12e-23 | 132 | 54 | 16 | CID000020796 |
| Drug | ticlopidine | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.76e-23 | 103 | 54 | 15 | CID000005472 |
| Drug | hydroxylysine | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.33e-23 | 109 | 54 | 15 | CID000001029 |
| Drug | AC1L1C2F | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 5.01e-23 | 110 | 54 | 15 | CID000001711 |
| Drug | PPACK | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 7.67e-23 | 113 | 54 | 15 | CID003036757 |
| Drug | AC1L9732 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 8.82e-23 | 114 | 54 | 15 | CID000439300 |
| Drug | Tranilast sodium | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.01e-22 | 115 | 54 | 15 | CID000005527 |
| Drug | pirfenidone | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.77e-21 | 138 | 54 | 15 | CID000040632 |
| Drug | DL-penicillamine | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.98e-21 | 139 | 54 | 15 | CID000004727 |
| Drug | PCR 4099 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.98e-21 | 139 | 54 | 15 | CID000002806 |
| Drug | AC1Q6PCP | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 ESRRA COL22A1 COL25A1 WNK4 | 2.21e-21 | 230 | 54 | 17 | CID000005267 |
| Drug | candesartan cilexetil | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 3.83e-21 | 145 | 54 | 15 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.13e-20 | 162 | 54 | 15 | CID000072363 |
| Drug | khellin | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.90e-20 | 171 | 54 | 15 | CID000003828 |
| Drug | AC1L1DD6 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 9.89e-20 | 179 | 54 | 15 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.27e-19 | 189 | 54 | 15 | CID000001413 |
| Drug | foscarnet | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.46e-19 | 190 | 54 | 15 | CID000003414 |
| Drug | prostacyclin sodium salt | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.58e-17 | 250 | 54 | 15 | CID000000159 |
| Drug | AC1L18QD | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 FOXG1 | 2.66e-17 | 325 | 54 | 16 | CID000000213 |
| Drug | hyaluronan | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 3.37e-17 | 263 | 54 | 15 | CID000024759 |
| Drug | silibinin | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 1.12e-16 | 285 | 54 | 15 | CID000005213 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 4.74e-16 | 314 | 54 | 15 | CID000447989 |
| Drug | L-3,4-dehydroproline | COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A3 COL11A1 COL13A1 COL22A1 COL25A1 | 1.29e-15 | 73 | 54 | 10 | CID000094284 |
| Drug | losartan | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 7.32e-15 | 378 | 54 | 15 | CID000003961 |
| Drug | colchine | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 8.87e-15 | 383 | 54 | 15 | CID000002833 |
| Drug | chondroitin sulfate | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.67e-14 | 413 | 54 | 15 | CID000024766 |
| Drug | Y-27632 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 7.66e-14 | 444 | 54 | 15 | CID000005711 |
| Drug | AC1L1KMJ | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.10e-13 | 476 | 54 | 15 | CID000030956 |
| Drug | aspirin | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.34e-12 | 563 | 54 | 15 | CID000002244 |
| Drug | NC-4 | 1.01e-11 | 44 | 54 | 7 | CID006420119 | |
| Drug | LMWH | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 2.37e-11 | 663 | 54 | 15 | CID000000772 |
| Drug | pyridinoline | 8.45e-11 | 99 | 54 | 8 | CID000105068 | |
| Drug | isodesmosine | 1.41e-10 | 33 | 54 | 6 | CID000013811 | |
| Drug | LS-63783 | COL4A5 COL5A1 COL6A1 COL24A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL11A2 COL13A1 COL27A1 COL22A1 COL25A1 | 3.49e-10 | 804 | 54 | 15 | CID000000231 |
| Drug | dermatan sulfate | COL4A5 COL5A1 COL6A1 COL6A3 COL9A1 COL9A3 COL11A1 COL11A2 COL27A1 | 2.27e-09 | 220 | 54 | 9 | CID000032756 |
| Drug | desmosine | 2.82e-09 | 53 | 54 | 6 | CID000025435 | |
| Drug | 1h00 | 3.96e-09 | 56 | 54 | 6 | CID000445950 | |
| Drug | 1zd2 | 7.06e-08 | 45 | 54 | 5 | CID004149241 | |
| Drug | gold nanoparticles | 1.02e-07 | 243 | 54 | 8 | CID000023985 | |
| Drug | 351A | 1.33e-07 | 20 | 54 | 4 | CID000122144 | |
| Drug | AC1L9HPX | 2.61e-06 | 92 | 54 | 5 | CID000445279 | |
| Drug | PD123177 | 3.26e-06 | 43 | 54 | 4 | CID000114899 | |
| Drug | sodium chloride | COL4A5 COL5A1 COL6A1 COL6A3 COL7A1 COL8A2 COL9A1 COL9A3 COL11A1 COL13A1 COL25A1 | 4.79e-06 | 865 | 54 | 11 | CID000000206 |
| Drug | 1-piperonylpiperazine | 5.52e-06 | 2 | 54 | 2 | CID000094426 | |
| Drug | 4-aminoazobenzene | 1.83e-05 | 66 | 54 | 4 | CID000006051 | |
| Drug | 2-amino-4,6-dinitrotoluene | 2.31e-05 | 70 | 54 | 4 | ctd:C035208 | |
| Drug | NSC-333492 | 3.30e-05 | 4 | 54 | 2 | CID000333256 | |
| Drug | fipexide | 5.50e-05 | 5 | 54 | 2 | CID000003351 | |
| Drug | Sirius red | 7.82e-05 | 35 | 54 | 3 | CID005486818 | |
| Drug | 17-isoprogesterone | COL4A5 COL5A1 COL6A1 COL7A1 COL8A2 COL11A1 COL11A2 KIZ COL27A1 ESRRA CHGA | 7.85e-05 | 1170 | 54 | 11 | CID000004920 |
| Drug | 17-AAG; Up 200; 1uM; PC3; HG-U133A | 7.88e-05 | 186 | 54 | 5 | 432_UP | |
| Drug | BPAT-143 | 8.23e-05 | 6 | 54 | 2 | CID000146249 | |
| Drug | In2-7 | 8.23e-05 | 6 | 54 | 2 | CID002816385 | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 9.38e-05 | 193 | 54 | 5 | 1236_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 54 | 5 | 4649_DN | |
| Drug | AC1MRIIV | 1.08e-04 | 39 | 54 | 3 | CID003518584 | |
| Drug | Pcme | 1.53e-04 | 8 | 54 | 2 | CID000169849 | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 2.57e-04 | 52 | 54 | 3 | ctd:C573693 | |
| Drug | MBMP | 3.00e-04 | 11 | 54 | 2 | CID000150994 | |
| Drug | kalinin | 3.03e-04 | 55 | 54 | 3 | CID000032518 | |
| Drug | haloperidol | 3.31e-04 | 394 | 54 | 6 | CID000003559 | |
| Drug | trapidil | 3.37e-04 | 57 | 54 | 3 | CID000005531 | |
| Drug | AC1Q641C | 4.32e-04 | 62 | 54 | 3 | CID000005005 | |
| Disease | Stickler syndrome | 5.46e-08 | 5 | 53 | 3 | cv:C0265253 | |
| Disease | Sensory hearing loss | 8.94e-07 | 11 | 53 | 3 | C1691779 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.54e-06 | 53 | 53 | 4 | C4707243 | |
| Disease | Fibrochondrogenesis | 3.17e-06 | 2 | 53 | 2 | C0265282 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 3.17e-06 | 2 | 53 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Stickler syndrome (implicated_via_orthology) | 3.17e-06 | 2 | 53 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.20e-06 | 19 | 53 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 6.10e-06 | 20 | 53 | 3 | C0026760 | |
| Disease | Sensorineural Hearing Loss (disorder) | 9.45e-06 | 23 | 53 | 3 | C0018784 | |
| Disease | Stickler syndrome (disorder) | 9.49e-06 | 3 | 53 | 2 | C0265253 | |
| Disease | Disproportionate short stature | 1.14e-05 | 77 | 53 | 4 | C0878659 | |
| Disease | Cleft Palate | 1.39e-05 | 81 | 53 | 4 | C0008925 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.89e-05 | 4 | 53 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 1.89e-05 | 4 | 53 | 2 | cv:C4551860 | |
| Disease | Stickler syndrome (is_implicated_in) | 1.89e-05 | 4 | 53 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | Bethlem myopathy | 1.89e-05 | 4 | 53 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.89e-05 | 4 | 53 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.89e-05 | 4 | 53 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.89e-05 | 4 | 53 | 2 | C0410179 | |
| Disease | Stickler syndrome, type 1 | 3.15e-05 | 5 | 53 | 2 | C2020284 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 3.15e-05 | 5 | 53 | 2 | cv:CN043640 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 3.15e-05 | 5 | 53 | 2 | 603932 | |
| Disease | Lumbar disc disease | 3.15e-05 | 5 | 53 | 2 | C0221775 | |
| Disease | Intervertebral disc disorder | 3.15e-05 | 5 | 53 | 2 | cv:C0158252 | |
| Disease | Early Pregnancy Loss | 4.49e-05 | 109 | 53 | 4 | C3830362 | |
| Disease | Miscarriage | 4.49e-05 | 109 | 53 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 4.49e-05 | 109 | 53 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 4.49e-05 | 109 | 53 | 4 | C0000822 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 4.73e-05 | 6 | 53 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Intervertebral disc disorder | 4.73e-05 | 6 | 53 | 2 | C0158252 | |
| Disease | Hereditary hearing loss and deafness | 1.40e-04 | 146 | 53 | 4 | cv:C0236038 | |
| Disease | corneal resistance factor | 1.54e-04 | 451 | 53 | 6 | EFO_0010067 | |
| Disease | central corneal thickness | 2.32e-04 | 309 | 53 | 5 | EFO_0005213 | |
| Disease | Connective Tissue Diseases | 2.44e-04 | 13 | 53 | 2 | C0009782 | |
| Disease | osteoarthritis (implicated_via_orthology) | 3.27e-04 | 15 | 53 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Myopia | 3.27e-04 | 15 | 53 | 2 | C0027092 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.74e-04 | 16 | 53 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 3.74e-04 | 16 | 53 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 3.74e-04 | 16 | 53 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.74e-04 | 16 | 53 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.74e-04 | 16 | 53 | 2 | C3541456 | |
| Disease | Van Buchem disease | 4.23e-04 | 17 | 53 | 2 | C0432272 | |
| Disease | Dyschondroplasias | 5.31e-04 | 19 | 53 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 5.31e-04 | 19 | 53 | 2 | C0029422 | |
| Disease | Disorder of eye | 5.76e-04 | 212 | 53 | 4 | C0015397 | |
| Disease | Neonatal diabetes mellitus | 9.25e-04 | 25 | 53 | 2 | C0158981 | |
| Disease | corneal topography | 1.00e-03 | 109 | 53 | 3 | EFO_0004345 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEGNEEQKGPPEGSE | 31 | Q12979 | |
| QGEVGKDGEKGDPGP | 201 | Q14050 | |
| GGGGPEEEPVDGLAG | 61 | P49640 | |
| EGAEIPGAEPEKMGG | 86 | Q8TAB5 | |
| PDQYKGEKGSEGEPG | 271 | P08572 | |
| GEGDQEPGLEPGDII | 226 | P31689 | |
| GEEGDGPPGGKEEDE | 571 | Q9HCE9 | |
| PERGKEPDLGGGEED | 326 | Q2M243 | |
| EPDLGGGEEDEGLEG | 331 | Q2M243 | |
| EQGGGEKGEDPELPG | 56 | Q8HWS3 | |
| GDPEGPEAGGAEQKA | 211 | P78411 | |
| PGPGLQGEEEQGEGD | 851 | Q9Y4B5 | |
| DGEGEPGQGEGPEAG | 306 | Q9NZM5 | |
| LGPDGEEAEGPGAGD | 146 | P18615 | |
| GKGGAEEPGAEELLG | 321 | P50219 | |
| PPGDDGMRGEDGEIG | 626 | P12107 | |
| SPGEDGDKGEIGEPG | 1121 | P12107 | |
| VGGDKGEDGDPGQPG | 1331 | P12107 | |
| GPDEKEKGAGAGGEE | 141 | P55316 | |
| GNEEEKGAPDAGPGL | 256 | Q76G19 | |
| GPKGEPGEQGEKGDA | 276 | Q9BXS0 | |
| PGEQGEKGDAGENGP | 281 | Q9BXS0 | |
| GENGPKGDTGEKGDP | 291 | Q9BXS0 | |
| PPGVAGEDGDKGEVG | 1076 | P13942 | |
| GEDGDKGEVGDPGQK | 1081 | P13942 | |
| QDGAKGDRGEDGEPG | 1286 | P13942 | |
| PNPGGKMEGEDGIEA | 396 | Q2M2Z5 | |
| GESGEAGQDGKPPGD | 396 | Q0VDD7 | |
| KGEAGDEGNPGPDGA | 406 | P12109 | |
| LGDRGEPGEDGEPGE | 336 | P25067 | |
| PGGEKGEKGEQGEPG | 281 | P29400 | |
| LDGLDGEDGDKGLPG | 2111 | P12111 | |
| VGPETGGEKNGPEEE | 1446 | Q3T8J9 | |
| GGEGGGVPEDLSLEE | 6 | O43739 | |
| PPGDDGERGDDGEVG | 656 | P20908 | |
| VGEKGEPGEAGEPGL | 1281 | P20908 | |
| AGQDGPPGDKGDDGE | 1356 | P20908 | |
| GEKGQEGLMGEDGPP | 1216 | Q8IZC6 | |
| GEKGDQGEKGELGLP | 816 | Q8NFW1 | |
| EPGPKGEQGASGEEG | 671 | P20849 | |
| GRDGEVGEKGDEGPP | 1631 | Q02388 | |
| EPGDPGEDGRKGEKG | 1846 | Q02388 | |
| LPGGELNPGEDEVEG | 106 | O43809 | |
| GEKGEAGEKGNPGAE | 551 | Q5TAT6 | |
| MEGEGGGETPEQPGL | 16 | Q96C19 | |
| KEEEDGEGAGPGEQG | 51 | P11474 | |
| PSGEEGDKGDVGAPG | 1071 | P25940 | |
| EEDPGPDGEGLLKQG | 686 | Q8N137 | |
| GPGGNEDGPQKLDSE | 386 | Q96LD4 | |
| GGAGGPPIQDEDEGE | 366 | Q9BZL4 | |
| GPQLPGEGEEEEEGE | 636 | Q76KP1 | |
| GKPGAEEAQDPEGKG | 281 | P10645 | |
| GGGDKPLADGEVPGD | 671 | Q16281 | |
| GEPGPEGLKGEVGDQ | 831 | Q17RW2 | |
| EGESGLQGEPGAKGD | 1016 | Q17RW2 | |
| GLPGEDGEKGEMGLP | 1071 | Q17RW2 | |
| GPGLSQGPGVDEGED | 1731 | Q8IWN7 | |
| EDEEDGVPGGNGTGP | 101 | Q5BIV9 | |
| PGGEDTEEQQPGKEG | 361 | Q86VE9 | |
| EMGPPDVEEEEGGGQ | 656 | Q9Y2I1 | |
| PGGQEEEEDGEGGPT | 251 | Q9NRS6 | |
| GVELQEGGDGPGAEE | 31 | Q15853 | |
| EEKEGGVEEAGGPPA | 191 | Q9UFB7 | |
| PGESEGGDQPKEEEG | 66 | Q96HH4 | |
| EEGDDGKEPQVGGSP | 1086 | Q96J92 | |
| GPRGEKGGGVDEDEE | 81 | Q9P2K6 |